Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.
Pharmaceutical Executive Europe  E-News
 
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecdigi
 
Survey
We asked 40 pharma leaders, Pharma agents and employees should never post messages that promote or mention brand name drugs, whether they remain anonymous or not.

Strongly agree 50%
Agree 13%
Disagree 25%
Strongly disagree 12%

Talk to us:
jupton@advanstar.com

Advertise with us: mgoodrich@advanstar.com

17 July, 2012
In this Issue
Are Emerging Markets Emerging Fast Enough?
The IMS Institute’s annual report on global drug spending predicts a slight rebound in developed markets, despite historically low growth rates. In emerging markets, growth continues to be robust, but is it enough to balance the ongoing stagnancy in Europe and the US? Read more...
Pharma Surges Ahead in Online Communication
It may surprise some working in the industry, but pharmaceutical companies, in particular those in Europe, rank among the world’s best online corporate communicators, according to a new report. More...
End of the Honeymoon Period — What Next for the iPad?
Since its launch two years ago, the iPad has enjoyed unprecedented success in the healthcare space. But how long can the technology captivate physicians? More...
Is Europe’s Health Research Focus Becoming Too Narrow?
A vote in the European Parliament’s health committee to back the “Health and Growth for Citizens” program suggests that the focus of European research in healthcare is becoming tighter and tighter on a selected range of topics, writes Reflector. More...
Also in this issue…
Q&A with Eli Lilly’s John Lechleiter
Latest Global Pharma Appointments
Upcoming Pharma Events